Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed)
National Institutes of Health
Posted on:
Type
Research/project funding
Funding Opportunity RFA-AG-23-014 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications for projects designed to understand molecular and cellular mechanisms underlying cerebral blood flow reduction in Alzheimers disease (AD) and Alzheimers disease-related dementias (ADRD).